Amany Ibrahim Mustafa
Professor
Metabolic syndrome in androgenetic alopecia patients; Is serum regulated on activation, normal T-cell expressed and secreted the missing link?
journalof cosmetic dermatology • 2021
Publication Information
Authors
Amany Ibraim Mustafa 1, Walid Abd Ellatif Abel Halim 2, Fawzy Eman 3, El-Habbak Doaa 1
Keywords
Not Available
Journal
journalof cosmetic dermatology
Publisher
Wiley
Volume
20
Issue
7
Pages
2270-2276
publication.type
International
Paper Link
Open Link
Supplementary Materials
Amany Ibrahim Mustafa_J of Cosmetic Dermatology - 2020 - Mustafa - Metabolic syndrome in androgenetic alopecia patients Is serum regulated on (3).pdf
Abstract
Background: Androgenetic alopecia (AGA) is the most common cause of hair loss affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the metabolic disorders in AGA patients is not completely elucidated.
Aims: Evaluation of the prevalence of MetS and the possible role of RANTES in pathogenesis of the MS among AGA patients.
Methods: A total of 160 subjects were enrolled in this work; included 100 patients clinically diagnosed with AGA and 60 apparently healthy control subjects. They were evaluated for MS components according to National Cholesterol Education Program (NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level using ELISA kits.
Results: Metabolic syndrome was present in 30.0% of AGA patients and in 10.0% of the control group (P = .038), Studied AGA patients showed significantly higher serum RANTES when compared to control group (P value < .001). Moreover, serum RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL-c levels in AGA patients with MetS.
Conclusion: Metabolic syndrome components were prevalent among AGA patients. Serum RANTES level was significantly higher in all AGA patients and specifically in those with MS as it was significantly positively correlated with some MetS components which reflects its possible role in pathogenesis of MetS in AGA patients.
Aims: Evaluation of the prevalence of MetS and the possible role of RANTES in pathogenesis of the MS among AGA patients.
Methods: A total of 160 subjects were enrolled in this work; included 100 patients clinically diagnosed with AGA and 60 apparently healthy control subjects. They were evaluated for MS components according to National Cholesterol Education Program (NCEP) adult treatment panel 3 (ATP3) and measurement of serum RANTES level using ELISA kits.
Results: Metabolic syndrome was present in 30.0% of AGA patients and in 10.0% of the control group (P = .038), Studied AGA patients showed significantly higher serum RANTES when compared to control group (P value < .001). Moreover, serum RANTES levels were significantly positively correlated with BMI, FBG, TC, and LDL-c levels in AGA patients with MetS.
Conclusion: Metabolic syndrome components were prevalent among AGA patients. Serum RANTES level was significantly higher in all AGA patients and specifically in those with MS as it was significantly positively correlated with some MetS components which reflects its possible role in pathogenesis of MetS in AGA patients.